首页> 外文期刊>Journal of Pharmacy and Pharmacology >The novel application of tertiary butyl alcohol in the preparation of hydrophobic drug-HPbetaCD complex.
【24h】

The novel application of tertiary butyl alcohol in the preparation of hydrophobic drug-HPbetaCD complex.

机译:叔丁醇在制备疏水性药物-HPbetaCD复合​​物中的新应用。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

This report describes a novel application of tertiary butyl alcohol (TBA) in the preparation of hydrophobic drug-hydroxypropyl beta-cyclodextrin (HPbetaCD) complex. The straightforward, economic preparation procedure consists of dissolving both the hydrophobic drug and HPbetaCD in TBA, which is subsequently freeze-dried to give the hydrophobic drug-HPbetaCD complex in the form of a porous powder. TBA was selected as the medium due to it being a good solvent for hydrophobic drug and HPbetaCD; in addition, it is also a versatile lyophilization medium and is widely used in pharmaceutical processes. In this study, ketoprofen and nitrendipine were used as model drugs and their HPbetaCD complexes were prepared by lyophilization of the TBA system. Based on the data from differential scanning calorimetry (DSC) and X-ray diffractometry (XRD), the drugs were amorphous in freeze-dried samples. The infra-red (IR) spectrum indicated that a drug-HPbetaCD interaction took place in the freeze-dried complex. Dissolution experiments showed that the hydrophobic drug dissolved rapidly from the HPbetaCD complex in both simulated gastric juice and simulated intestinal fluid. These results confirmed that this technique produced a hydrophobic drug-HPbetaCD complex. TBA was found to be a suitable freeze-drying medium for the preparation of hydrophobic drug-HPbetaCD complex. This approach is versatile, energy-conserving and can easily be scaled up. It is expected to have further application in modifying the physicochemical characteristics of hydrophobic drugs and improving their absorption and pharmacodynamic properties.
机译:该报告描述了叔丁醇(TBA)在疏水性药物-羟丙基β-环糊精(HPbetaCD)复合物的制备中的新应用。简单,经济的制备程序包括将疏水性药物和HPbetaCD都溶解在TBA中,然后将其冷冻干燥,以形成多孔粉末形式的疏水性药物-HPbetaCD复合​​物。选择TBA作为介质是因为它是疏水性药物和HPbetaCD的良好溶剂。此外,它还是一种通用的冻干介质,广泛用于制药过程。在这项研究中,将酮洛芬和尼群地平用作模型药物,并通过冻干TBA系统制备其HPbetaCD复合​​物。根据差示扫描量热法(DSC)和X射线衍射法(XRD)的数据,这些药物在冻干样品中是无定形的。红外(IR)光谱表明在冷冻干燥的复合物中发生了药物-HPbetaCD相互作用。溶出实验表明,疏水性药物从HPbetaCD复合​​物中迅速溶解在模拟胃液和模拟肠液中。这些结果证实了该技术产生了疏水性药物-HPbetaCD复合​​物。发现TBA是用于制备疏水性药物-HPbetaCD复合​​物的合适的冷冻干燥介质。这种方法是通用的,节能的,并且可以轻松扩展。有望在改变疏水性药物的理化特性,改善其吸收和药效特性方面有进一步的应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号